BioPioneers Angel & Pre-Seed Playbook event - February 2026

BioPioneers’ Angel & Pre-Seed Playbook was a masterclass in what actually gets the first check in biotech/techbio:

Top takeaways

- Scientists often jump to mechanism — investors first need the problem, stakes, and market.

- At pre-seed, it’s mostly team + narrative; the seed bar is rising fast (more proof expected).

- In TechBio/AI: more data ≠ more value. Show a feedback loop, proprietary/credible biology, and a few sharp use cases.

- Fundraising mechanics matter: party rounds scare later investors, and messy SAFE/notes can over-dilute founders at conversion.

- The fastest way to level up: talk to customers early, get operator/advisor help, and learn the basics of economics + milestones.

- Platform vs asset: a platform without an asset can look like a science project, and an asset without a platform can be a single-shot bet—the strongest stories prove the platform via a clear first use case, then expand into multiple shots on goal.

How to find serial “station masters” (repeat operators/angels): follow recent exits, scan the boards/advisors of companies 2–3 steps ahead of you, show up at accelerators/demo days, and get warm intros from founders who’ve already raised.

Grateful to our panelists for the candor: 

Elena Itskovich, PhD - Founding General Partner, Nest Catalyst

Sammy Datwani, Ph.D. - Board Director, Life Science Angels; CEO and Co-founder, Prisma

Anastasia Budinskaya - Principal, NFX

Lavanya Anandan, Ph.D. - Executive in Residence, UCSF Innovation Ventures and 

Dana Foss, PhD - Co-Founder & CEO, Editpep for moderating.

Thankful to our sponsors for making this meetup possible - Leader Bank (Vida Nazari) + TheAgentic (Gulia IR) + DropXcell (Luke Blauch, PhD) + MBC BioLabs (Leah Makley, Rachel Hatano, PhD)